InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,490.39
(
0.14%
)
US TECH 100
19,284.40
(
0.10%
)
Dow Jones
39,201.44
(
0.10%
)
Brent Oil
85.01
(
-0.48%
)
Bitcoin
60,754.50
(
-1.39%
)
Post# of 252415
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

masterlongevity

Send PM Follow Ignore
Followers 25
Posts 2597
Boards Moderated 0
Alias Born 01/07/2004

masterlongevity

Re: genisi post# 110621

Sunday, 12/12/2010 1:24:04 PM

Sunday, December 12, 2010 1:24:04 PM

Post# of 252415
this is addressed in Roche's slideset. THe PPMS population is very heterogenous. They did a post-hoc on the Rituxan data and there were some groups who responded much more favorably. they will be going after a more defined PPMS group with Ocrelizumab
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up